Volume Loss in Deep Gray Matter and Thalamic Sub-Nuclei in Placebo-treated Patients with Multiple Sclerosis in the Phase 3 TEMSO study

被引：0
|
作者：
Gaetano, Laura [1 ]
Magon, Stefano [1 ]
Chakravarty, Mallar [2 ]
Kappos, Ludwig [3 ]
Sprenger, Till [3 ]
Cavalier, Steven [4 ]
Roesch, Nora [4 ]
Thangavelu, Karthinathan [4 ]
Wuerfel, Jens [1 ]
机构：
[1] Med Image Anal Ctr, Basel, Switzerland
[2] McGill Univ, Cerebral Imaging Ctr, Montreal, PQ, Canada
[3] Univ Hosp Basel, Neurol, Basel, Switzerland
[4] Sanofi, Cambridge, MA USA
来源：
NEUROLOGY | 2019年 / 92卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P5.2-070
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Volume Loss in Deep Gray Matter and Thalamic Sub-Nuclei in Placebo-Treated Patients with Multiple Sclerosis in the Phase 3 Temso Study
    Gaetano, Laura
    Magon, Stefano
    Chakravarty, Mallar
    Kappos, Ludwig
    Sprenger, Till
    Cavalier, Steven J.
    Roesch, Nora
    Thangavelu, Karthinathan
    Wuerfel, Jens
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 110 - 111
  • [2] Deep Grey Matter and Thalamic Nuclei Volume Loss Correlation With WholeBrain Volume Loss in Patients With MS From the TEMSO Study
    Wuerfel, J.
    Magon, S.
    Chakravarty, M. M.
    Kappos, L.
    Roesch, N.
    Poole, E.
    Sprenger, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 482 - 482
  • [3] Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis
    Stefano Magon
    Charidimos Tsagkas
    Laura Gaetano
    Raihaan Patel
    Yvonne Naegelin
    Michael Amann
    Katrin Parmar
    Athina Papadopoulou
    Jens Wuerfel
    Christoph Stippich
    Ludwig Kappos
    M. Mallar Chakravarty
    Till Sprenger
    Journal of Neurology, 2020, 267 : 1536 - 1546
  • [4] Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis
    Magon, Stefano
    Tsagkas, Charidimos
    Gaetano, Laura
    Patel, Raihaan
    Naegelin, Yvonne
    Amann, Michael
    Parmar, Katrin
    Papadopoulou, Athina
    Wuerfel, Jens
    Stippich, Christoph
    Kappos, Ludwig
    Chakravarty, M. Mallar
    Sprenger, Till
    JOURNAL OF NEUROLOGY, 2020, 267 (05) : 1536 - 1546
  • [5] Deep gray matter Volume Loss drives the Disability Worsening in Patients with Multiple Sclerosis
    Kriegeskorte, Volker
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2018, 86 (08)
  • [6] Effect of natalizumab on cortical gray matter and thalamic volume loss versus a historical placebo in early relapsing remitting multiple sclerosis
    Nakamura, Kunio
    Perumal, Jai
    Balabanov, Roumen
    Balcer, Laura
    Galetta, Steven
    Sun, Zhaonan
    Li, Hanyue
    Avila, Robin
    Rutledge, Danette
    Fox, Robert J.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 375 - 376
  • [7] Deep gray matter volume loss drives disability worsening in multiple sclerosis
    Eshaghi, Arman
    Prados, Ferran
    Brownlee, Wallace J.
    Altmann, Daniel R.
    Tur, Carmen
    Cardoso, M. Jorge
    De Angelis, Floriana
    van de Pavert, Steven H.
    Cawley, Niamh
    De Stefano, Nicola
    Stromillo, M. Laura
    Battaglini, Marco
    Ruggieri, Serena
    Gasperini, Claudio
    Filippi, Massimo
    Rocca, Maria A.
    Rovira, Alex
    Sastre-Garriga, Jaume
    Vrenken, Hugo
    Leurs, Cyra E.
    Killestein, Joep
    Pirpamer, Lukas
    Enzinger, Christian
    Ourselin, Sebastien
    Wheeler-Kingshott, Claudia A. M. Gandini
    Chard, Declan
    Thompson, Alan J.
    Alexander, Daniel C.
    Barkhof, Frederik
    Ciccarelli, Olga
    ANNALS OF NEUROLOGY, 2018, 83 (02) : 210 - 222
  • [8] Natalizumab reduces loss of gray matter and thalamic volume in patients with relapsing-remitting multiple sclerosis: A post hoc analysis from the randomized, placebo-controlled AFFIRM trial
    Nakamura, Kunio
    Sun, Zhaonan
    Hara-Cleaver, Claire
    Bodhinathan, Karthik
    Avila, Robin L.
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (06) : 687 - 695
  • [9] Gray Matter Volume Loss Is Increased in Younger Patients with Relapsing Multiple Sclerosis but Minimized by Ozanimod: Experience From the Ozanimod Phase 3 Program
    Schippling, Sven
    Cree, Bruce A. C.
    Montalban, Xavier
    Arnold, Douglas L.
    Kappos, Ludwig
    Comi, Giancarlo
    Bodhinathan, Karthik
    Chen, Yu
    Sheffield, James K.
    Silva, Diego
    NEUROLOGY, 2019, 92 (15)
  • [10] Deep gray matter damage in multiple sclerosis patients: Correlation between magnetization transfer ratios and volume
    Ikonomidou, Vasiliki N.
    Pellegrini, Stefano
    Gallo, Antonio
    Evangelou, Iordanis E.
    Ohayon, Joan M.
    Ehrmantraut, Mary
    Cantor, Fredric
    McFarland, Henry
    Bagnato, Francesca
    NEUROLOGY, 2008, 70 (11) : A470 - A470
12345